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into monoacylglycerol and FFAs, which can then be taken 
up into the cells. Angptl4 can also induce lipolysis in adi-
pocytes ( 1–4 ). For adipocytes, the net metabolic effect of 
Angptl4 is to mobilize lipids to plasma. The importance of 
Angptl4 in the regulation of lipid homeostasis is supported 
by a series of physiological studies ( 2, 5 ). First, injecting 
ANGPTL4 recombinant proteins rapidly increases plasma 
TG and FFA levels ( 5, 6 ). Mice overexpressing Angptl4 in 
muscle and adipose tissue have increased plasma TG levels 
( 7 ), and adenoviral-mediated overexpression of  Angptl4 in 
liver causes hyperlipidemia and hepatic steatosis ( 8 ). Sec-
ond, compared with WT mice, those lacking  Angptl4 gene 
( Angptl4   /   ) are hypolipidemic and have lower plasma 
FFA levels ( 9, 10 ). Furthermore, treating mice with Angptl4 
antibody reduces plasma TG levels ( 11 ). When fed with 
high-fat diet,  Angptl4   /   mice become obese faster than 
WT mice ( 12 ). However, these mice eventually develop fi -
brinopurulent peritonitis, ascites, intestinal fi brosis, and 
cachexia ( 9 ). Finally, genetic studies also support the criti-
cal role of Angptl4 in the regulation of lipid homeostasis. 
Population-based sequencing of human  ANGPTL4 gene 
uncovered genetic variations that contribute to a reduced 
level of plasma TG ( 13 ). Also, serum ANGPTL4 levels and 
white adipose tissue (WAT) ANGPTL4 expression are in-
versely correlated in monozygotic twins. 
 The expression of  Angptl4 gene is modulated by vari-
ous signals. Thiazolidinedione, fi brate, and FFA induce 
 Angptl4 transcription through members of the PPAR fam-
ily, PPAR  ,   , and   /  , respectively ( 14, 15 ). Hypoxia and 
transforming growth factor   also activate  Angptl4 tran-
scription ( 16–18 ). Our group previously showed that glu-
cocorticoids stimulate  Angptl4 transcription in adipocytes 
 Abstract  Angiopoietin-like 4 (Angptl4) is a glucocorticoid re-
ceptor (GR) primary target gene in hepatocytes and adipo-
cytes. It encodes a secreted protein that inhibits extracellular 
LPL and promotes adipocyte lipolysis. In  Angptl4 null mice, 
glucocorticoid-induced adipocyte lipolysis and hepatic ste-
atosis are compromised. Markedly, insulin suppressed 
glucocorticoid-induced  Angptl4 transcription. To unravel the 
mechanism, we utilized small molecules to inhibit insulin 
signaling components and found that phosphatidylinositol 
3-kinase and Akt were vital for the suppression in H4IIE cells. 
A forkhead box transcription factor response element ( FRE ) 
was found near the 15 bp  Angptl4 glucocorticoid response ele-
ment ( GRE ). Mutating the  Angptl4 FRE signifi cantly reduced 
glucocorticoid-induced reporter gene expression in cells. More-
over, chromatin immunoprecipitation revealed that GR and 
FoxO1 were recruited to  Angptl4 GRE and  FRE in a glucocor-
ticoid-dependent manner, and cotreatment with insulin abol-
ished both recruitments. Furthermore, in 24 h fasted mice, 
signifi cant occupancy of GR and FoxO1 at the  Angptl4 GRE and 
 FRE was found in the liver. In contrast, both occupancies 
were diminished after 24 h refeeding. Finally, overexpression 
of dominant negative FoxO1 mutant abolished glucocorti-
coid-induced  Angptl4 expression, mimicking the insulin sup-
pression.  Overall, we demonstrate that both GR and FoxO1 
are required for  Angptl4 transcription activation, and that 
FoxO1 negatively mediates the suppressive effect of insulin. —
Kuo, T., T-C. Chen, S. Yan, F. Foo, C. Ching, A. McQueen, 
and J-C. Wang.  Repression of glucocorticoid-stimulated an-
giopoietin-like 4 gene transcription by insulin.  J. Lipid Res . 
2014. 55:  919–928. 
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 Angiopoietin-like 4  ( Angptl4 ), also known as the fast-
ing-induced adipose factor, or Fiaf, encodes a secreted 
protein that inhibits LPL activity ( 1–3 ). LPL hydrolyzes 
TGs in lipoproteins, such as chylomicrons and VLDLs, 
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Research Center Inc.). To synthesize randomly primed cDNA, 
0.5   g of total RNA, 4   l of 2.5 mM 2’-deoxynucleoside 5’-
triphosphate, and 2   l of 15   M random primers (New England 
Biolabs) were mixed at a volume of 16   l and incubated at 70°C 
for 10 min. Then, a 4   l cocktail containing 25 units of Moloney 
Murine Leukemia Virus Reverse Transcriptase (New England 
Biolabs), 10 units of RNasin (Promega) and 2   l of 10× reaction 
buffer (New England Biolabs) was added and incubated at 42°C 
for 1 h and then 95°C for 5 min. The cDNA was diluted appro-
priately for real-time quantitative PCR (qPCR) using the EVA 
QPCR SuperMix Kit (Biochain) following the manufacturer’s 
protocol. qPCR was performed in a StepOne PCR System 
(Applied Biosystems) and analyzed with the    -Ct method, as 
supplied by the manufacturer.  Rpl19 gene expression was used 
for internal normalization. Mouse primers used were mRpl19_
cDNA_Fo: ATGGAGCACATCCACAAGC; mRpl19_cDNA_Re: 
TCCTTG GTCTTAGACCTGCG; mAngptl4_cDNA_Fo: AAGAT-
GCACAGCATCACAGG; and mAngptl4_cDNA_Re: ATGGAT-
GGGAAATTGGAGC. Rat primers used were rRPL19_cDNA_Fo: 
ACAAGCGGATTCTCATGGAG; rRPL19_cDNA_Re: TCC TT-
GGTCTTAGACCTGCG; rAngptl4_cDNA_Fo: AGACC CG AA-
GGA TAGAGTCCC; and rAngptl4_cDNA_Re: CC TT C TGG AACA-
GTTGCTGG. 
 Plasmids, transfection, and luciferase reporter assay 
 Reporter plasmids harboring different GR binding regions 
(GBRs) were cotransfected with pcDNA3-hGR (150 ng) and pRL 
Renilla (100 ng) into H4IIE cells in 12-well plates. pGL4.10-E4TATA 
reporter plasmid was generated by insertion of a 50 bp minimal  E4 
TATA promoter sequence into the  Bgl II to  Hind III sites of vector 
pGL4.10 to drive luciferase expression. Different lengths of the 
Angptl4 GBR regions were then inserted into the upstream of  Kpn I 
and  Xho I sites of E4 TATA sequences. The QuikChange Lightning 
mutagenesis kit (Stratagene) was used to make site-directed muta-
tions per the manufacturer’s instructions. Lipofectamine 2000 (In-
vitrogen) was used to transfect H4IIE cells according to the technical 
manual. Twenty-four hours posttransfection, cells were treated with 
control ethanol, 0.5   M Dex, 1 nM insulin in DMEM only for 16–20 h. 
Cells were then harvested, and their luciferase activities were mea-
sured with the Dual-Luciferase Reporter Assay kit (Promega) ac-
cording to the technical manual. Cloning primers used were Luc_
rAngptl4_KpnI_+6529bp: gctgcaGGTACCgctcttgttacctgctatgt; Luc_
rAngptl4_XhoI_+6030bp: cgctctCTCGAGtggagatgcagagggacca; 
Luc_rAngptl4_KpnI_+6376bp: gctgcaGGTACCggaagctgaaatcactggga; 
Luc_rAngptl4_XhoI_+6181bp: cgctctCTCGAGggttccaaggcacagctca; 
and Luc_rAngptl4_KpnI_+6244bp: gctgcaGGTACCcagagaacaaaat-
gttctgagg. Mutagenesis primers used were Luc_rAngptl4_mt-
FOX_sense: CAAAGTTGGAGTAAAGATGTTCCTCGGGTGGAG 
and Luc_rAngptl4_mtFOX_antisense: CTCCACCCGAGGAACA-
TCTTTA C TCCACACTTTG. Human expression vector for domi-
nant negative Akt was described previously ( 26 ) and was provided 
by Dr. Gary Firestone (University of California Berkeley). 
 Chromatin immunoprecipitation assay 
 H4IIE cells (1 × 10 8 to 2 × 10 8 cells) were treated with control 
ethanol, 0.5 µM Dex, 1 nM insulin, or a combination of Dex and 
insulin for 30 min, followed by cross-linking with formaldehyde 
at a fi nal concentration of 1% at room temperature for 5 min. 
The reactions were quenched with 0.125 M glycine. The cells 
were then washed twice with 1× PBS and scraped and lysed in cell 
lysis buffer (50 mM HEPES-KOH at pH 7.4, 1 mM EDTA, 150 mM 
NaCl, 10% glycerol, 0.5% Triton X-100), supplemented with pro-
tease inhibitor (PI) cocktails (Calbiochem). The cell lysate was 
incubated for 15 min at 4°C, and the crude nuclear extract was 
collected by centrifugation at 600  g for 5 min at 4°C. The nuclei 
were resuspended in 1 ml of ice-cold RIPA buffer (10 mM Tris-HCL 
and hepatocytes ( 19 ). A glucocorticoid response element 
( GRE ) was identifi ed in 3 ′ untranslated region of rat  Angptl4 
gene and is located between +6,267 and +6,241 [relative 
to transcription start site (TSS)] ( 19 ). The  Angptl4 GRE 
sequence is conserved within rat, mouse, and human. 
Notably,  Angptl4 expression is highly induced upon fast-
ing, and glucocorticoid signaling is required for this 
fasting response ( 20 ). Physiological studies further con-
fi rmed that Angptl4 is involved in glucocorticoid-regulated 
lipid metabolism. Excess glucocorticoid-induced fatty liver 
and hyperlipidemia are protected in  Angptl4   /   mice ( 19 ). 
Further more, glucocorticoid-induced lipolysis in WAT is 
reduced in  Angptl4   /   mice ( 20 ). 
 Previous studies have shown that serum ANGPTL4 levels 
and the expression of ANGPTL4 are inversely correlated 
with insulin sensitivity ( 21–23 ). In 3T3-L1 adipocytes, insu-
lin suppresses  Angptl4 gene expression ( 24, 25 ). Notably, in 
adipocytes, glucocorticoids promote lipolysis, whereas insu-
lin inhibits this process. Moreover, insulin resistance could 
lead to dyslipidemia and hepatic steatosis, which both can 
be a result of excess or prolonged glucocorticoid exposure. 
Based on these data, we propose that insulin suppresses 
glucocorticoid-induced  Angptl4 transcription to antagonize 
glucocorticoid-modulated lipid metabolism. In this report, 
we investigated the effect of insulin on glucocorticoid-
stimulated  Angptl4 gene expression and unraveled the 
transcriptional mechanism underlying insulin-suppressed 
glucocorticoid-induced  Angptl4 transcription. 
 MATERIALS AND METHODS 
 Cell culture 
 H4IIE rat hepatoma cells were cultured in DMEM (Mediatech) 
with 5% FBS (Tissue Culture Biologicals) and incubated at 37°C 
with 5% CO 2 . For all cell culture experiments, H4IIE cells were 
grown to 95% confl uence, and treatments were diluted in DMEM 
only and applied to cultured cells. Rat primary hepatocytes were 
provided by the Cell Biology Core of University of California, San 
Francisco Liver Center. Treatments were applied as follows: 0.5   M 
dexamethasone (Dex; Sigma D4902), 1 nM insulin (Sigma I9278), 
10   M phosphatidylinositol 3-kinase (PI3K) inhibitor GDC-09410 
(Selleck S1064), 5   M Akt inhibitor API -2 (Tocris 2151), 0.5 nM 
mammalian target of rapamycin (mTOR) inhibitor MK-8669 (also 
known as deforolimus, Selleck S1022), 200 nM S6 kinase (S6K) in-
hibitor rapamycin (Cayman 13346), and 5   M glycogen synthase 
kinase (GSK) inhibitor SB-216763 (Tocris 1616). 
 Animals 
 Male 8-week-old C57BL/6 mice were purchased from Charles 
River. The control group of mice was continuously fed, while the 
experimental group of mice was fasted for 24 h starting at 10 AM, 
or fasted and refed the next morning at 10 AM for 24 h. Then, 
the mice were euthanized, and their liver tissues were collected at 
the same time. The Offi ce of Laboratory Animal Care at the Uni-
versity of California, Berkeley (#R306-0111) approved all animal 
experiments conducted. 
 RNA isolation and quantitative PCR 
 Total RNA from H4IIE cells was isolated using Nucleospin 
RNA II kit (Macherey-Nagel 740955), and total RNA from 
mouse liver was prepared with TRI Reagent® RT (Molecular 
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Hormonal regulation of Angptl4 gene transcription 921
applied to resuspend the nuclei pellet for sonication at 60% out-
put for fi ve times, 10 s each. To remove insoluble components, 
the samples were centrifuged at 13,000 rpm for 15 min at 4°C, 
and the supernatant was collected. Then, 3 vol of dilution buffer 
(20 mM Tris-HCl at pH 8.0, 2 mM EDTA, 200 mM NaCl, 1% 
Triton X-100, and 0.1% Na-deoxycholate) was added to the su-
pernatant, and 100   l of 50% protein A/G plus-agarose bead 
slurry with 5   g of IgG antibody was added to each sample for 
preclearing at 4°C for 1 h with gentle shaking. Then, the sample 
was centrifuged at 4,000 rpm at 4°C for 3 min, 100   l of the su-
pernantant was saved for input, and the rest was divided accord-
ingly for immunoprecipitation overnight. The next day, 60   l of 
50% protein A/G plus-agarose bead slurry was applied, and the 
samples were nutated for 2 h at 4°C. The following 500   l washes 
were done, all supplemented with PI: once with TSE I (20 mM 
Tris-HCl at pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100, 
and 0.1% SDS); once with TSE II (20 mM Tris-HCl at pH 8.0, 
2 mM EDTA, 500 mM NaCl, 1% Triton X-100, and 0.1% SDS); 
once with TSE III (10 mM Tris-HCl at pH 8.0, 1 mM EDTA, 0.25 M 
LiCl, 1% NP-40, and 1% Na-deoxycholate), and twice with TE 
(10 mM Tris-HCl at pH 8.0 and 1 mM EDTA) buffer. Centrifuga-
tion at 8,000 rpm at 4°C for 1 min was used to remove supernatant 
between washes. Freshly prepared 400   l elution buffer (100 mM 
NaHCO 3 and 1% SDS) was added to each sample, and elution 
buffer (up to 400   l in total) was added for input. The samples 
were nutated for 1 h at room temperature. To reverse the cross-
linking, after centrifugation, supernatant was transferred to new 
Eppendorf tubes, and a fi nal concentration of 200 mM NaCl was 
added to each sample, followed by 65°C water bath incubation 
for >6 h. The next day, 8   l of 0.5 M EDTA, 16   l of 1 M Tris-HCL 
at pH 6.5, and 1.5   l of 25 mM proteinase K were added to each 
sample, followed by 65°C water bath incubation for 1 h. To purify 
DNA, chloroform extraction was done for each sample, and real-
time qPCR was carried out for data analysis. 
 Adenovirus infection and Western blotting 
 FoxO1  256 adenoviruses were provided from Dr. Mimmo Ac-
cili (Columbia University) ( 27 ), which express human infl uenza 
hemagglutinin (HA) epitope tag-containing proteins. H4IIE cells 
were infected with adenoviruses for 48 h, followed by 5–6 h treat-
ment of control ethanol, 0.5   M Dex, or Dex plus 1 nM insulin. 
Antibody against HA tag (Roche 11583816001) was used to detect 
the overexpression level of FoxO1, and GAPDH (abcam ab9483) 
was included as internal control. 
 RESULTS 
 Insulin suppressed glucocorticoid-induced  Angptl4 gene 
expression 
 Mouse primary hepatocytes were treated with 0.5 µM of 
Dex (a synthetic glucocorticoid), 1 nM insulin, a combina-
tion of insulin and Dex, or ethanol (vehicle control) for 5 h. 
At the end of the treatment, RNA was isolated from these 
cells, and reverse transcription was performed. Real-time 
PCR (qPCR) was then used to monitor the expression of 
 Angptl4 . We found that  Angptl4 gene expression was   3.4-
fold higher in Dex-treated cells than ethanol-treated cells 
( Fig. 1A ).  Although insulin treatment did not signifi cantly 
decrease  Angptl4 expression, insulin treatment abolished 
Dex-induced  Angptl4 expression ( Fig. 1A ). 
 We previously showed that Dex markedly augmented 
the expression of  Angptl4 in rat H4IIE hepatoma cells. We thus 
examined whether insulin inhibited  Angptl4 expression 
at pH 8.0, 1 mM EDTA, 150 mM NaCl, 5% glycerol, 1% Triton 
X-100, 0.1% sodium deoxycholate, 0.1% SDS, supplemented 
with PI). The chromatin was fragmented on ice with Branson 
Sonifi er 250 sonicator (4 min total, 20 s pulse at 30% power fol-
lowed by 40 s pause). To remove insoluble components, the sam-
ples were centrifuged at 13,000 rpm for 15 min at 4°C, and the 
supernatant was collected. Fifty to 100   l supernatant was ali-
quoted as input, and the rest of supernatant was divided equally 
for antibody addition. One and half micrograms of normal rabbit 
IgG antibody (sc-2027, Santa Cruz Biotechnology), 2.5   g of 
rabbit polyclonal anti-GR antibody (IA-1), 4   g of FoxO1 antibody 
(sc-11350×, Santa Cruz Biotechnology), 4   g of FoxO3 antibody 
(07-702, Millipore), or 4   g of hepatic nuclear factor-3  /FoxA2 
antibody (sc-9187×, Santa Cruz Biotechnology) was added to the 
supernatant and nutated at 4°C overnight. Our GR antibody, 
IA-1, was raised in a rabbit against a synthetic peptide comprising 
residues 75–103 of human GR. The IA-1 antibody was purifi ed 
from the serum by binding to human GR fragment 27–506 
immobilized to agarose beads (Sterogene Actigel), then eluted at 
low pH. The eluted antibody was neutralized, concentrated to 
1 µg/µl, and stored at   80°C. We found IA-1 to be at least as 
specifi c for GR by western and chromatin immunoprecipitation 
(ChIP) sequencing compared with the published N499 and 
H-300 (SC-8992, Santa Cruz Biotechnology). 
 The next day, 100   l of 50% protein A/G plus-agarose bead 
slurry (Santa Cruz Biotechnology) was added into each immuno-
precipitated sample and nutated for 2 h at 4°C. These washes 
followed: twice with RIPA buffer, twice with RIPA buffer contain-
ing 500 mM NaCl, twice with LiCl buffer (20 mM Tris at pH 8.0, 
1 mM EDTA, 250 mM LiCl, 0.5% Tergitol-type NP-40 (NP-40, 
nonyl phenoxypolyethoxylethanol) , 0.5% sodiumdeoxycholate), 
and one last time with RIPA buffer. After removing the remaining 
wash buffer, 75   l of proteinase K solution (Tris-EDTA (TE) at 
pH 8.0, 0.7% SDS, 200   g/ml proteinase K) was added to each 
immunoprecipitation reaction, followed by incubation at 55°C 
for 3 h and 65°C overnight to reverse formaldehyde cross-linking. 
ChIP DNA fragments were purifi ed with QIAquick PCR purifi ca-
tion kit (Qiagen), eluting in 60–120   l of Qiagen Elution Buffer. 
ChIP DNA samples were then subjected to real-time qPCR analy-
sis with the following primers: rAngptl4_ChIP_+6093bp_Fo: 
TTGACCGACTGGAGATAGGG and rAngptl4_ChIP_+6205bp_
Re: ATGTTGTGAGCTGTGCCTTG. 
 Mouse liver ChIP assay 
 Liver tissues were harvested from control and experimental 
groups of C57BL/6 mice, minced with a razor blade, and col-
lected in 1× SSC buffer (150 mM NaCl and 15 mM sodium cit-
rate). Samples were then washed on a nutator, followed by cen-
trifugation at 4,000 rpm for 3 min at 4°C to remove supernatant. 
The liver pellets were resuspended in PBS and cross-linked with 
1% formaldehyde for 15 min at room temperature with gentle 
shaking, and the reaction was quenched with the addition of gly-
cine. Centrifugation followed to remove supernatant, and the 
cell pellets were washed with ice-cold PBS plus PI with shaking. 
Once PBS was removed, the cells were resuspended in hypotonic 
buffer (10 mM HEPES at pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 
0.2% NP-40, 1 mM EDTA, 5% sucrose) with PI, 1.5 mM sper-
mine, and 0.5 mM spermidine added right before use. Cells were 
homogenized using Polytron PT 2100 homogenizer for four 
pulses of 10 s each. Homogenized cells in hypotonic buffer are 
mounted onto cushion buffer (10 mM Tris-HCl at pH 7.5, 15 mM 
NaCl, 60 mM KCl, 1 mM EDTA, 10% sucrose, with PI, 1.5 mM 
spermine, and 0.5 mM spermidine added right before use) and 
centrifuged at 4,000 rpm at 4°C for 5 min, followed by the re-
moval of supernatant. SDS-sonication buffer (50 mM Tris-HCl at 
pH 8.0, 2 mM EDTA, and 1% SDS added right before use) was 
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of each signaling protein in the insulin signaling pathway 
were applied ( Fig. 1B ). In detail, GDC-0941 inhibits class I 
PI3K ( 28 ), whereas API-2 inhibits Akt ( 29 ). MK-8669 and 
rapamycin inhibited mTORC1 ( 30, 31 ), which results in a 
reduction of p70 S6K activity. In addition, the GSK-3  inhibi-
tor SB-216763 was used to mimic insulin effect ( 32 ), as Akt 
inhibits GSK-3  . We found that MK-8669 and rapamycin 
treatment did not affect insulin response, whereas GDC-0941 
and API-2 signifi cantly reduced the ability of insulin to in-
hibit Dex-induced  Angptl4 gene expression (from 1.1-fold to 
2.7- and 28.7-fold, respectively,  Fig. 1A ). Most likely, PI3K and 
Akt participate in the observed insulin repression, whereas 
mTORC1 does not. Moreover, cotreatment of Dex and 
SB-216763 reduced glucocorticoid-induced  Angptl4 
from 18.9- to 6.5-fold ( Fig. 1A ), suggesting that inhibiting 
in H4IIE cells. H4IIE cells were treated with 0.5 µM of Dex, 
1 nM insulin, a combination of insulin and Dex, or ethanol 
for 5 h. Gene expression of  Angptl4 was then performed. In-
deed, we found that Dex increased  Angptl4 expression   18.9-
fold ( Fig. 1A ). Insulin treatment abolished this induction 
( Fig. 1A ), whereas insulin alone did not signifi cantly affect 
 Angptl4 expression. Overall, these results support that the 
H4IIE cell line is a viable cell culture model for studying the 
mechanism of insulin effect on  Angptl4 expression. 
 Identifi cation of signaling molecules in insulin signaling 
pathway required to inhibit glucocorticoid-induced 
 Angptl4 gene expression 
 To learn how insulin inhibits Dex-induced  Angptl4 ex-
pression, various small molecules that inhibit the activity 
 Fig.  1. Gene expression of Angptl4. A: Mouse primary hepatocytes and H4IIE hepatoma cells were treated 
with control ethanol (EtOH), 0.5 µM Dex, 1 nM insulin, or Dex plus insulin, and in combination with one of 
the following inhibitors: 10 µM PI3K inhibitor GDC-0941, 5 µM Akt inhibitor API-2, 0.5 nM MK-8669 and 
200 nM rapamycin, two TORC1 inhibitors, or 5 µM GSK inhibitor SB-216763. RNA isolation and RT-qPCR fol-
lowed. Primers specifi c to Angptl4 and Rpl19 (internal control) gene were used in qPCR. Fold induction was 
calculated by normalizing to Rpl19 and taking the ratio of treatment over ethanol. Error bars indicate standard 
error of the mean. B: Schematic presentation of insulin signaling pathway in hepatocytes. Small-molecule in-
hibitors used to inhibit insulin signaling components are shown. C: Mouse primary adipocytes were treated 
with control ethanol (EtOH), 0.5 µM Dex, 1 nM insulin, or Dex plus insulin for 5 h. The expression of Angptl4 
was assessed by RT-qPCR. Error bars indicate standard error of the mean. *  P < 0.05 and n  	 3. 
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Hormonal regulation of Angptl4 gene transcription 923
 Previous studies have demonstrated that  FRE can cooper-
ate with  GRE to confer a maximal glucocorticoid response on 
gluconeogenic genes, such as phosphoenolpyruvate car-
boxykinase  ( Pepck ) and glucose-6-phosphatase  ( G6Pase ). No-
tably, the role of the  FRE in Dex-activated  Angptl4 transcription 
cannot be answered by comparing the Dex response on 
pDel-3 and pDel-4 reporters, because the  Angptl4 GRE in 
pDel-4 is located 132 bp closer to the luciferase TSS than 
pDel-3 ( Fig. 2A ). The distance between the  GRE and the basal 
transcription machinery could affect the magnitude of hor-
mone response. Therefore, to learn whether the  FRE is re-
quired for maximal Dex response in  Angptl4 , we mutated one 
nucleotide in the  FRE in pWT to obtain pMut-FRE ( Fig. 2C ). 
With the mutated  FRE , Dex-induced luciferase activity was 
signifi cantly reduced 66% ( Fig. 2D , from 100% to 34%), 
which indicates that this  FRE is essential for conferring gluco-
corticoid response. For pWT reporter, insulin treatment re-
duced 80% of Dex response ( Fig. 2D ). For pMut-FRE, the 
ability of insulin to suppress Dex-induced luciferase activity 
was greatly reduced ( Fig. 2D ). These results again confi rm 
the important role of this  FRE in mediating the repressive ef-
fect of insulin. The reason that pMut-FRE still responded to 
insulin is likely because a single nucleotide mutation in  FRE 
did not entirely eliminate the binding of FoxA2, FoxO1, 
and/or FoxO3 to this element. This is in contrast to pDel-4, 
in which the deletion of the entire  FRE results in a complete 
loss of insulin response. 
 In  Fig. 1A , we showed that Akt was involved in insulin-
repressed glucocorticoid-induced  Angptl4 expression. To test 
whether Akt directly regulates  Angptl4 transcription through 
the  GBR , we cotransfected an expression vector harboring a 
dominant negative form of Akt (DN Akt) with pWT into 
H4IIE cells. As shown in  Fig. 2E , insulin suppressed   80% 
of Dex-induced pWT activity. With cotransfection of 0.3   g 
DN Akt, insulin only repressed   50% of Dex-induced pWT 
activity. Furthermore, cotransfection of 0.6   g DN Akt com-
pletely abolished insulin suppression ( Fig. 2E ). These re-
sults suggest that Akt is involved in the repressive effect of 
insulin on the enhancer activity of the  Angptl4 GBR . 
 The recruitment of GR and FoxO1 to the rat  Angptl4 GBR 
 We performed ChIP with specifi c antibodies against GR, 
FoxA2, FoxO1, and FoxO3 to determine which of them were 
recruited to the  Angptl4 GBR . H4IIE cells were treated with 
ethanol, Dex, insulin, or a combination of insulin and Dex 
for 30 min, followed by ChIP assay. At basal condition under 
ethanol treatment, there was no signifi cant GR recruitment 
at the  Angptl4 GBR ( Fig. 3 ).  With Dex treatment, we observed 
signifi cant GR occupancy ( Fig. 3 ). Moreover, FoxO1 was re-
cruited to the  Angptl4 GBR with Dex treatment ( Fig. 3 ). 
Interestingly, insulin treatment abolished Dex-induced re-
cruitment of both GR and FoxO1 to the  Angptl4 GBR ( Fig. 3 ). 
The recruitment of FoxA2 and FoxO3 with Dex treatment 
did not reach statistical signifi cance, with  P values of 0.07 and 
0.79, respectively (FoxO3 data was not shown). 
 The recruitment of GR and FoxO1 to the mouse  Angptl4 
GBR in vivo 
 To examine whether GR and FoxO1 are recruited to 
the mouse  Angptl4 GBR in a similar pattern in vivo, we 
GSK-3  mimicked the repressive effect of insulin on 
glucocorticoid-induced  Angptl4 expression. 
 We also examined whether insulin suppresses Dex-
induced  Angptl4 expression in mouse primary adipocytes. 
We treated mouse primary adipocytes isolated from epididy-
mal fat depots with ethanol, Dex, insulin, and Dex plus in-
sulin for 5 h. RNA was isolated from these cells, and qPCR 
was used to monitor  Angptl4 expression. We found that Dex 
increased  Angptl4 expression   1.5-fold ( Fig. 1C ). This in-
duction was abolished by insulin treatment ( Fig. 1C ). Insu-
lin treatment alone did not reduce  Angptl4 expression 
statistically; however, the trend of  Angptl4 expression was 
lower in insulin-treated cells than in ethanol-treated ones. 
 FOX response element is required for maximal 
glucocorticoid-induced Angptl4 transcription 
 The 500 bp  GBR of rat  Angptl4 , located from nt position 
+6,030 to +6,529 relative to its TSS, was inserted upstream 
of a luciferase reporter plasmid pGL4.10-E4TATA ( 33, 34 )
to create pWT ( Fig. 2A ).  Dex treatment increased the ac-
tivity of this reporter gene 12.7-fold ( Fig. 2B ), and a con-
sensus  GRE was previously identifi ed at nt +6,228 to +6,242 
( 19 ). Here, we showed that insulin was able to suppress 
Dex-induced reporter gene activity from 12.7-fold to 4.8-
fold ( Fig. 2B ). This indicates that pWT contains  cis -acting 
elements that mediate Dex and insulin effects. 
 To locate the  cis -acting elements responsible for insulin 
suppression, we deleted portions of pWT to get pDel-1, 
pDel-2, and pDel-3, which contain the genomic region of 
rat  Angptl4 nt +6,030 to +6,376; nt +6,181 to +6,529; and nt 
+6,181 to +6,376 relative to its TSS, respectively ( Fig. 2A ). 
Markedly, insulin was able to suppress Dex response in all 
three reporter genes. These results suggest that  cis -acting 
elements mediating Dex and insulin effects are located 
within nt +6,181 and +6,376. 
 We used TFSEARCH (http://www.cbrc.jp/research/
db/TFSEARCH.html) to look for binding motif(s) for 
other transcription factors close to the  Angptl4 GRE . Binding 
motifs for Sex determining region Y protein (SRY), Acute 
myeloid leukemia 1 protein (AML1), TATA, GR, FoxA2 
(also known as HNF-3  ), Ikaros-1 (IK-1), Ik-2, and Ik-3 
were found when we set the threshold at 85 ( Fig. 2C ). 
Among them, FoxA2 binding motif and its potential 
binding proteins, FoxA2, FoxO1, and FoxO3, have a di-
rect link to insulin signaling. Akt has been reported to 
phosphorylate and export FoxA2, FoxO1, and FoxO3 
from the nucleus, thereby inactivating these transcription 
factor proteins ( 35, 36 ). For simplicity, this FoxA2 binding 
site will be referred to as the Forkhead box (FOX) re-
sponse element ( FRE ) from now on. 
 To examine whether the  Angptl4 FRE relayed the sup-
pression of insulin on glucocorticoid-induced  Angptl4 ex-
pression, we constructed the pDel-4 reporter, in which the 
 FRE region was deleted from the pDel-3 reporter gene 
( Fig. 2A ). Dex treatment markedly increased the activity of 
this pDel-4 reporter gene ( Fig. 2B ). However, insulin was 
unable to repress Dex response ( Fig. 2B ). These results 
suggested that the  FRE plays a critical role in the repressive 
function of insulin on Dex-induced  Angptl4 . 
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monitored the occupancy of these transcription factors 
upon fasting and refeeding cycle. Fasting elevates circulat-
ing corticosterone levels, while refeeding increases plasma 
insulin levels. Mice were fasted for 24 h from 10 AM. The 
next morning at 10 AM, food was replenished along with 
 Fig.  2. Mutagenesis and reporter assay reveal the importance of Fox binding site to glucocorticoid re-
sponse. The 15 bp GRE of  Angptl4 is located at chr17: 33,911,836 to 33,911,850, equivalent to nt position 
+6,229 to +6,243 relative to  Angptl4 TSS. All nt positions shown are relative to rat Angptl4 TSS. A: WT GBR 
(+6,030 to +6,529) is inserted upstream of a luciferase gene in reporter plasmid pGL4.10-E4TATA (denoted 
as pWT). Deletions of WT GBR give the following reporter plasmids: pDel-1 (nt +6,030 to +6,376), pDel-2 
(nt +6,181 to +6,529), pDel-3 (nt +6,181 to +6,376), and pDel-4 (nt +6,181 to +6,244). B: Reporter plasmids 
(250 ng) described in A were cotransfected with a human GR expression vector (150 ng) and a Renilla internal 
control plasmid (50 ng) into H4IIE cells. Twenty-four hours posttransfection, cells were treated with control 
ethanol (EtOH), 0.5 µM Dex, 1 nM insulin, or Dex plus insulin for 20–24 h. Fold induction is calculated by 
taking the ratio of treatment over ethanol. C: GRE and FRE of rat Angptl4 are shown. The nt +6,324 of FRE 
is mutated from C to G for mutant FRE (pMut-FRE). D: Reporter assays described in B were carried out for 
pWT and pMut-FRE. Ethanol-treated pWT luciferase activity was set as 0%, while Dex-treated pWT was 100%. 
E: pWT (250 ng) was cotransfected with a human GR expression vector (150 ng), a Renilla internal control 
plasmid (50 ng), and a human expression vector for dominant negative Akt (DN Akt; 300 or 600 ng) into 
H4IIE cells. Twenty-four hours posttransfection, cells were treated with control ethanol, 0.5 µM Dex, 1 nM 
insulin, or Dex plus insulin for 20–24 h. The results are presented as relative activities to Dex-induced pWT 
reporter activity. Error bars represent standard error of the mean. **  P < 0.05 for relative activity with no DN 
Akt cotransfection versus relative activity with DN Akt cotransfection; N.D. indicates no difference. Error 
bars represent standard error of the mean. *  P < 0.05. 
5% glucose included in the drinking water. After 24 h, 
liver tissues were collected for gene expression and ChIP 
assays. The three groups were  1 ) continuous feeding (ad 
libitum),  2 ) 24 h fasting (fasted), and  3 ) 24 h fasting fol-
lowed by 24 h refeeding (fasted/refed). Liver tissues were 
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is believed to act dominant negatively, as it can bind to its 
cognate  cis -acting element but cannot synergize with GR 
to activate gene transcription. Indeed, compared with the 
overexpression of control LacZ (Ad-LacZ), FoxO1  256 
overexpression (Ad-FoxO1  256 ) markedly reduced the 
ability of Dex to increase  Angptl4 expression in H4IIE cells 
( Fig. 5 ).  Furthermore, when FoxO1  256 was overex-
pressed, insulin treatment did not signifi cantly suppress 
Dex-induced  Angptl4 expression. These results indicate 
that FoxO1 mediates the suppressive effect of insulin on 
Dex-induced  Angptl4 expression. Under basal conditions, 
 Angptl4 expression increased   2-fold in FoxO1  256-
overexpressing cells ( Fig. 5 ). Notably, FoxO1 did not oc-
cupy  Angptl4 FRE when H4IIE cells were treated with 
ethanol ( Fig. 3 ). Therefore, it is unlikely that FoxO1  256 
directly regulates basal  Angptl4 expression. The increased 
basal  Angptl4 expression is likely due to indirect effect of 
FoxO1  256 in H4IIE cells. 
 DISCUSSION 
 In this report, we have identifi ed several novel aspects of 
the mechanism governing the transcriptional regulation 
of  Angptl4 gene by glucocorticoids (GCs) and insulin. We 
found that an  Angptl4 FRE , located close to the  Angptl4 
GRE , is vital for a maximal GC response in  Angptl4 tran-
scription ( Fig. 6A ).  FoxO1 is recruited to this  FRE in a GC-
dependent manner both in vitro and in vivo, and the 
transactivation domain of FoxO1 is required for the GC 
response. Moreover, insulin represses GC-induced  Angptl4 
transcription through the activation of PI3K and Akt ( Fig. 
6B ). In contrast, mTORC1 and its downstream effectors 
are not involved in this process. Furthermore, the  Angptl4 
FRE is also required for the repressive effect of insulin on 
GC-induced  Angptl4 transcription. With the presence of 
insulin, the recruitment of FoxO1 and GR to their respec-
tive response elements is markedly reduced ( Fig. 6B ), 
which results in decreased GC response. Such a phenom-
enon is also confi rmed in vivo. Upon fasting, which ele-
vates circulating corticosterone levels and keeps insulin 
levels low, GR and FoxO1 occupy their respective response 
collected at the same time. We found that  Angptl4 expres-
sion in 24 h fasted animals was 4-fold higher than that of 
ad libitum mice ( Fig. 4A ).  After refeeding for 24 h,  Angptl4 
expression returned to levels the same as the ad libitum 
mice ( Fig. 4A ). With ChIP assay, in fasted mice both GR 
and FoxO1 occupied the  Angptl4 GBR ( Fig. 4B ). In con-
trast, in fasted/refed mice, the occupancy of these two 
transcription factors diminished greatly ( Fig. 4B ). These 
results were reminiscent of our observations in H4IIE cells. 
In ad libitum mice, we detected signifi cant GR occupancy 
on the  GRE ( Fig. 4B ). However, FoxO1 was absent from 
the  FRE ( Fig. 4B ). It is important to note that there is no 
induction of  Angptl4 expression in ad libitum mice. These 
results further support the notion that the  FRE is required 
for glucocorticoid-activated  Angptl4 . In summary, high 
glucocorticoid levels result in the recruitment of GR and 
FoxO1 to the  Angptl4 GBR , whereas high insulin levels dis-
rupt this recruitment. 
 Overexpression of FoxO1 mutant lacking transactivation 
domain abolished the effects of glucocorticoids and 
insulin on  Angptl4 gene 
 To further test the importance of the  Angptl4 FRE in glu-
cocorticoid- and insulin-regulated  Angptl4 transcription, 
we overexpressed a mutant form of FoxO1 protein with 
adenoviral system in H4IIE cells. The FoxO1 mutant 
FoxO1  256 lacks the transactivation domain. FoxO1  256 
 Fig.  3.  ChIP shows that insulin treatment abolished Dex-induced 
GR and FoxO1 recruitment. H4IIE cells were treated with control 
ethanol, 0.5 µM Dex, 1 nM insulin, or a combination of Dex and insu-
lin for 30 min, followed by ChIP with antibody against IgG, GR, FoxO1, 
and FoxA2. Primer used here fl anks nt +6,093 and +6,205 relative to 
 Angptl4 TSS. Error bars indicate SEM . *  P < 0.05. 
 Fig.  4. In vivo (A) Angptl4 gene expression and (B) ChIP assay during fasting and refeeding cycle. 
C57BL/6 mice were treated as follows:  1 ) ad libitum (Ad Lib),  2 ) fasted for 24 h (Fast), and  3 ) fasted for 24 h 
then refed for 24 h (Fast/Re-fed). Error bars indicate standard error of the mean. *  P < 0.05. 
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absence of insulin repression on basal  Angptl4 expression 
in H4IIE cells from our experiments. In mouse 3T3-L1 
adipocytes, previous studies reported that basal  Angptl4 ex-
pression was suppressed by insulin ( 24, 25 ). These fi nd-
ings suggest that insulin exerts tissue-specifi c effects on 
basal  Angptl4 expression. Alternatively, insulin may sup-
press  Angptl4 expression in mouse primary hepatocytes 
and rat H4IIE hepatoma cells at time point(s) that we did 
not examine. FoxO1 is implicated in insulin-repressed 
basal  Angptl4 expression in 3T3-L1 cells ( 24 ). It would be 
interesting to test whether the  Angptl4 FRE we identifi ed 
here associates with FoxO1 in 3T3-L1 adipocytes under 
basal conditions. 
 So far, we know that FoxO1 plays a critical role in GC-
activated  Angptl4 transcription. ChIP experiments in 
mouse liver showed that GR occupied the  Angptl4 GRE 
during ad libitum and fasted states. However, the expres-
sion of  Angptl4 was markedly lower in the ad libitum state 
than in the fasted state. This is likely due to the absence of 
FoxO1 on the  Angptl4 FRE during the ad libitum state. It 
appears that the transactivation domain of FoxO1 is re-
quired for GC response to  Angptl4 , as overexpression of 
FoxO1  256 hindered Dex-induced  Angptl4 transcription 
in H4IIE cells. Most likely, the assembly of the transcrip-
tional regulatory complex, one that includes GR, FoxO1, 
and their associated coregulatory proteins, is required to 
confer maximal GC response to  Angptl4 transcription. The 
fact that insulin treatment, which leads to FoxO1 exclu-
sion from the nucleus, signifi cantly reduced the recruit-
ment of GR to the  Angptl4 GRE suggests that the association 
of FoxO1 with the  Angptl4 FRE is required for the stable 
interaction between GR and the  Angptl4 GRE . Similar 
mechanisms were found in the regulation of  Pepck gene. 
The transactivation domain of FoxA2 was required for a 
complete GC response on rat  Pepck gene transcription 
( 45 ), and the binding of FoxA2 and/or FoxO1 to its  Pepck 
FRE (also known as the insulin response sequence or ac-
cessory element 2) potentiates the association of GR to the 
elements. However, after refeeding, circulating insulin lev-
els are increased, and the occupancies of both GR and 
FoxO1 on their respective response elements are mark-
edly reduced. Notably, ChIP sequencing results from the 
Encyclopedia of DNA Elements (ENCODE) Consortium 
found that there is a binding site for FoxO1 adjacent to 
the GRE of 3 ′ untranslated region of human  ANGPTL4 
gene (University of California, Santa Cruz genome 
browser). Likely, this mechanism of FoxO1 and GR-coreg-
ulated  Angptl4 transcription is conserved in humans. 
 The mechanism of insulin-repressed GC-induced 
 Angptl4 transcription is reminiscent of the mechanism of 
the transcriptional regulation of two important gluconeo-
genic genes:  Pepck and  G6Pase . For all three genes, their 
 FRE s are required for both GC and insulin response 
( 37–39 ). Moreover, the insulin repression acts through 
PI3K and Akt, whereas mTORC1 is not involved ( 40, 41 ). 
Insulin indirectly activates PI3K, which in turn increases 
the activity of Akt for FoxO1 phosphorylation and leads to 
the exclusion of FoxO1 from the nucleus to cytosol. Gsk3, 
which is inactivated by Akt, has been reported to potenti-
ate FoxO1 activity for  Pepck and  G6Pase expression ( 42, 
43 ). Our data showed that inhibiting Gsk3 activity mim-
icked insulin repression on GC-induced  Angptl4 expres-
sion. However, these results did not confi rm that Gsk3 is 
required for the insulin repression, as Akt can directly in-
activate FoxO1. In fact, a previous study suggested that 
Gsk3 is not involved in insulin-repressed  Pepck and  G6Pase 
expression in vivo, despite the pharmacological inhibition 
of Gsk3 mimicking the repressive effect of insulin ( 42 ). 
 There is one key feature that is distinct between the reg-
ulation of  Angptl4 and the two previously mentioned glu-
coneogenic genes. FoxO1 binds to its respective  FRE s in 
the  Pepck and the  G6Pase promoters prior to GC treatment 
( 39, 44 ). In contrast, FoxO1 is recruited to the  Angptl4 FRE 
only upon GC treatment. This difference may explain the 
 Fig.  5. FoxO1 mediates insulin response on Dex-induced Angptl4 
gene expression. H4IIE cells were infected with adenovirus carry-
ing control LacZ (Ad-LacZ) or mutant FoxO1 lacking transacti-
vation domain (Ad-FoxO1  256 ). A: Immunoblotting shows 
overexpression levels. B: After 48 h of infection, cells were treated 
with control ethanol, Dex, or a combination of Dex plus insulin for 
6 h, followed by RT-qPCR for Angptl4 gene expression. Fold induc-
tion was calculated by normalizing to Rpl19 and taking the ratio of 
treatment over ethanol. Error bars indicate standard error of the 
mean. *  P < 0.05; N.D. indicates no difference. 
 Fig.  6. Proposed mechanism of Angptl4 transcription. A: When 
glucocorticoids are present without insulin, FoxO1 binds to the 
 Angptl4 FRE and helps GR transcribe  Angptl4 . B: When both gluco-
corticoid and insulin are present, Akt inactivates FoxO1 by phos-
phorylation, which results in the export of FoxO1 from the nucleus. 
Without FoxO1 protein, glucocorticoid-induced  Angptl4 gene ex-
pression is greatly reduced. 
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 Pepck GRE ( 46 ). Notably, GR by itself does not bind to  Pepck 
GRE well ( 47 ), whereas GR binds the  Angptl4 GRE greatly 
as this  GRE is a perfect palindromic consensus  GRE (AGAA-
CAnnnTGTTCT) ( 19 ). This notion was further supported 
by our results, in which in the ad libitum state signifi cant 
numbers of GRs occupied the  GRE even though FoxO1 
was absent from the  FRE . 
 One of major metabolic functions of Angptl4 is to mo-
bilize fatty acids from adipocytes to circulating plasma by 
inhibiting extracellular LPL and promoting intracellu-
lar lipolysis in adipocytes. This aspect is physiologically 
important during fasting and starvation and is consis-
tent with the physiological function of GCs. Increased 
Angptl4 proteins induced by GCs in liver can also enter 
circulation to promote lipid mobilization as mentioned. 
In contrast, insulin suppresses lipolysis and therefore an-
tagonizes the effect of GCs on  Angptl4 transcription. 
Moreover, insulin also inhibits the transcription of an-
other GC-induced lipolytic gene, adipocyte TG lipase 
( Atgl , also known as desnutrin) ( 48 ). The  Atgl GRE has 
not been identifi ed; however, FoxO1 has been shown to 
activate  Atgl gene transcription ( 49 ). The expression of 
FoxO1 is induced by GCs in adipocytes ( 50, 51 ). Thus, 
FoxO1 might mediate the GC response on the  Atgl gene 
as well. Intriguingly, FoxO1 appears to be essential for a 
maximal GC response of genes that are repressed by in-
sulin, including  Angptl4 , Pepck , and  G6Pase . In opposition 
to their antagonist effects on lipolysis, GCs have been re-
ported to synergize with insulin to potentiate lipogenesis 
( 52–55 ). However, FoxO1 has been reported to suppress 
lipogenic  screbp-1c gene expression ( 56 ). Furthermore, 
FoxO1 can reduce hepatic lipogenic Chrebp protein sta-
bility ( 57 ). 
 Therefore, we speculate that insulin-controlled FoxO1 
participates not only in certain aspects of GC functions 
but also plays a pivotal role in determining the effects of 
GCs on lipid metabolism. We have previously shown that 
GCs activate lipolysis and lipogenesis concurrently in 
WATs ( 51 ). We hypothesize with results from the current 
studies that in adipocytes high FoxO1 activity aids the li-
polytic effects of GCs. On the contrary, with low FoxO1 
activity, as in the presence of insulin, GC-induced lipo-
genesis is favored. Future studies will test the proposed 
model and therefore provide insights into the funda-
mental understanding of insulin and glucocorticoid ac-
tions.  
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